Lumida
/ANNX
⌘K
Annexon Inc

Annexon Inc

ANNX
$4.14USD-5.26%-0.23 today

MARKET CAP

784.9M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$2
$7

AI Summary

Stalk
Sell NowMedium

ANNX is in a Stage 3 distribution phase, trading below its 9, 20, and 50 EMAs after failing to sustain rallies. Medium-term bias is bearish, favoring sells on rallies into the dynamic resistance zone around the short-term EMAs. Short-term rejection at the EMAs confirms immediate execution. Long-term trend remains up above the 200-day SMA but is at risk if price breaks decisively lower.

  • GBS FORWARD trial showed rapid, clinically meaningful responses; BLA filing targeted Q4 2026
  • Needham affirmed Buy rating and $25 price target after August trial announcement
  • Persistent negative profitability and earnings yield indicate weak financial viability
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICTREND
Sales, Adj.
YoY %
P / Sales
EV / Sales
Gross Profit, Adj.
YoY %
Margin %
EV / Gross Profit
EBITDA, Adj.
YoY %
Margin %
EV / EBITDA
EBIT
YoY %
Margin %
EV / EBIT
Net Income
YoY %
Net Margin
EPS (GAAP)
YoY %